Ausgabe 4/2022
Inhalt (23 Artikel)
Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease
Pierfrancesco Visaggi, Lucia Mariani, Federica Baiano Svizzero, Luca Tarducci, Andrea Sostilio, Marzio Frazzoni, Salvatore Tolone, Roberto Penagini, Leonardo Frazzoni, Linda Ceccarelli, Vincenzo Savarino, Massimo Bellini, Prakash C. Gyawali, Edoardo V. Savarino, Nicola de Bortoli
Increasing incidence of eosinophilic esophagitis in Sweden: a nationwide population study
John J. Garber, Paul J. Lochhead, Amiko M. Uchida, Bjorn Roelstraete, David Bergman, Mark S. Clements, Jonas F. Ludvigsson
Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study
John J. Garber, Bjorn Roelstraete, Paul J. Lochhead, Amiko M. Uchida, Karl Michaëlsson, Ola Olén, Jonas F. Ludvigsson
Distal esophageal wall thickness correlates with dysphagia in adult patients with eosinophilic esophagitis
Stephanie Wong, Marcus Tippett, Joshua Zobel, Romina Safaeian, Richard H. Holloway, Andrew Ruszkiewicz, Nam Q. Nguyen
International trends in esophageal cancer incidence rates by histological subtype (1990–2012) and prediction of the rates to 2030
Yushi Lin, Hong-liang Wang, Kailu Fang, Yang Zheng, Jie Wu
A survey of the clinical outcomes of cervical esophageal carcinoma surgery focusing on the presence or absence of laryngectomy using the National Clinical Database in Japan
Yasuaki Nakajima, Hisateru Tachimori, Yutaka Miyawaki, Naoto Fujiwara, Kenro Kawada, Hiroshi Sato, Hiroaki Miyata, Shinichi Sakuramoto, Hideaki Shimada, Masayuki Watanabe, Yoshihiro Kakeji, Yuichiro Doki, Yuko Kitagawa
Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer
Kazuchika Ohno, Motomi Nasu, Hidetoshi Matsui, Yoshifumi Baba, Takushi Yasuda, Jun Sakuma, Kenichiro Ikeda, Takashi Maruo, Takumi Okuda, Norihiko Narita, Hisayuki Kato, Taiji Kawasaki, Hiroshi Sato, Kunihiko Tokashiki, Naoki Akisada, Hajime Ishinaga, Ken Akashi, Kenji Okami, Kosuke Murayama, Soichiro Yamamoto, Yuji Kumakura, Kenro Kawada, Akihiro Shiotani, Takahiro Asakage
Handgrip strength predicts early postoperative dysphagia after thoracoscopic–laparoscopic esophagectomy in male patients with esophageal cancer
Daisuke Kurita, Daichi Utsunomiya, Kentaro Kubo, Yusuke Fujii, Kyohei Kanematsu, Koshiro Ishiyama, Junya Oguma, Hiroyuki Daiko
Early postoperative weight loss is associated with poor prognosis in patients with esophageal cancer
Kei Yamamoto, Koji Tanaka, Makoto Yamasaki, Kotaro Yamashita, Tomoki Makino, Takuro Saito, Kazuyoshi Yamamoto, Tsuyoshi Takahashi, Yukinori Kurokawa, Kiyokazu Nakajima, Hidetoshi Eguchi, Yuichiro Doki
Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors
Linlin Ji, Jianping Wang, Bo Yang, Jianping Zhu, Yini Wang, Jiaqi Jiao, Kai Zhu, Min Zhang, Liqiang Zhai, Tongqing Gong, Changqing Sun, Jun Qin, Guangshun Wang
Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
Masaaki Ito, Takaki Hiwasa, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Shu-Yang Li, Yasuo Iwadate, Kazuo Sugimoto, Masahiro Mori, Satoshi Kuwabara, Hirotaka Takizawa, Hideaki Shimada
Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
Noriyuki Nishiwaki, Kazuhiro Noma, Tomoyoshi Kunitomo, Masashi Hashimoto, Naoaki Maeda, Shunsuke Tanabe, Kazufumi Sakurama, Yasuhiro Shirakawa, Toshiyoshi Fujiwara
Patterns of failure after salvage chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer: 20-year experience in a single institution in Japan
Keiichi Jingu, Rei Umezawa, Takaya Yamamoto, Noriyoshi Takahashi, Kazuya Takeda, Yu Suzuki, Keita Kishida, So Omata, Yuta Sato, Noriyuki Kadoya
Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma
Renma Ito, Yoshiaki Nakamura, Hironori Sunakawa, Hisashi Fujiwara, Hidehiro Hojo, Naoki Nakamura, Takeo Fujita, Tomonori Yano, Hiroyuki Daiko, Tetsuo Akimoto, Takayuki Yoshino, Takashi Kojima
The benefit of concurrent chemotherapy with radiotherapy for esophageal cancer is limited in Asian patients aged 80 years or older: a SEER database analysis
Keiichi Jingu, Noriyoshi Takahashi, Rei Umezawa, Takaya Yamamoto, Kazuya Takeda, Yu Suzuki, Keita Kishida, So Omata, Yuta Sato, Hinako Harada, Ayaka Harigai
Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy
Sifen Wang, Chao Zhang, Yuting Wang, Kongjia Luo, Yuxian Yang, Yadi Yang, Shiliang Liu, Qiaoqiao Li, Mian Xi
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial
V. Noronha, V. M. Patil, N. S. Menon, A. Joshi, S. Goud, S. More, S. Kannan, A. Pawar, D. Nakti, A. Yadav, S. Shah, A. Mahajan, A. Janu, R. Kumar, A. Tibdewal, N. Mummudi, J. P. Agarwal, S. D. Banavali, K. Prabhash
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
Takashi Kojima, Hiroki Hara, Akihito Tsuji, Hisateru Yasui, Kei Muro, Taroh Satoh, Takashi Ogata, Ryu Ishihara, Masahiro Goto, Hideo Baba, Tomohiro Nishina, Shirong Han, Tomoko Sakata, Naoyoshi Yatsuzuka, Toshihiko Doi, Ken Kato
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma
Jhe-Cyuan Guo, Chia-Chi Lin, Chia-Lang Hsu, Ta-Chen Huang, Hung-Yang Kuo, Chen-Yuan Lin, Ming-Yu Lien, Ann-Lii Cheng, Chih-Hung Hsu
Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303)
Takashi Kojima, Ken Kato, Hiroki Hara, Shunji Takahashi, Kei Muro, Tomohiro Nishina, Masashi Wakabayashi, Shogo Nomura, Akihiro Sato, Atsushi Ohtsu, Toshihiko Doi
A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404)
Motoo Nomura, Takayuki Kii, Junji Kawada, Masashi Hirota, Takashi Ohta, Jin Matsuyama, Daisuke Sakai, Toshio Shimokawa, Yukinori Kurokawa, Hisato Kawakami, Toshimasa Tsujinaka, Taroh Satoh
Factors affecting the completion of concurrent chemotherapy and impact of non-completion on survival in locally advanced esophageal squamous cell carcinoma
Shijia Wang, Baoyan Ji, Chen Li, Weiming Han, Xin Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Nan Bi, Lei Deng, Wenqing Wang, Tao Zhang, Zefen Xiao
Correction to: Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 and Part 2
Yuko Kitagawa, Takashi Uno, Tsuneo Oyama, Ken Kato, Hiroyuki Kato, Hirofumi Kawakubo, Osamu Kawamura, Motoyasu Kusano, Hiroyuki Kuwano, Hiroya Takeuchi, Yasushi Toh, Yuichiro Doki, Yoshio Naomoto, Kenji Nemoto, Eisuke Booka, Hisahiro Matsubara, Tatsuya Miyazaki, Manabu Muto, Akio Yanagisawa, Masahiro Yoshida